Showing 7701-7710 of 18164 results for "".
Understanding Antibody-Mediated Demyelinating Diseases: Key Differences From MS
https://reachmd.com/programs/neurofrontiers/understanding-antibody-mediated-demyelinating-diseases-key-differences-from-ms/32821/Antibody-mediated demyelinating diseases, such as neuromyelitis optica spectrum disorder and MOG antibody disease, differ fundamentally from multiple sclerosis (MS) due to their association with specific antibodies. Dr. Michael Levy explains how these conditions progress, how relapses can driNicotinamide for COVID-19 Recovery: Restoring Metabolic Balance
https://reachmd.com/programs/clinicians-roundtable/nicotinamide-for-covid-19-recovery-restoring-metabolic-balance/36410/Transforming Clinician Wellness: EEG Headphones Helping with Burnout
https://reachmd.com/programs/neurofrontiers/transforming-clinician-wellness-eeg-headphones-helping-with-burnout/32872/Neuro-responsive EEG headphones are helping healthcare professionals combat burnout by promoting calm, focus, and resilience. Backed by neuroscience and real-time brain monitoring, this personalized technology blends music and neurofeedback to optimize mental states and reduce stress. Hear from VitaReducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
https://reachmd.com/programs/neurofrontiers/reducing-cortical-lesions-in-ms-with-ocrelizumab-results-from-the-oratori-study/26763/Does the B-cell therapy ocrelizumab have the potential to slow down cortical lesions or even stop them in multiple sclerosis (MS)? That’s the exact question the ORATORI study sought to answer, and based on the findings, not only did ocrelizumab reduce new and enlarging cortical lesions by 75 percentChairperson’s Perspective: Treating At-Risk MASH: What Are You Waiting For?
https://reachmd.com/programs/cme/chairpersons-perspective-treating-at-risk-mash-what-are-you-waiting-for/28862/Listen in to learn about best practices for treating patients with at-risk MASH, presented at MASH-TAG 2025 in Park City, Utah.Optimizing Nutritional Support for Patients with Duchenne Muscular Dystrophy
https://reachmd.com/programs/neurofrontiers/optimizing-nutritional-support-for-patients-with-duchenne-muscular-dystrophy/26328/Explore essential strategies, tips, and tricks we can employ to optimize nutritional support for patients with DMD.A Clinician’s Action Guide for Psoriasis Awareness Month
https://reachmd.com/programs/dermconsult/a-clinicians-action-guide-for-psoriasis-awareness-month/24125/Here’s how you can support patients, educate the public, and become a patient advocate during Psoriasis Awareness Month and beyond.Dr. Emile Bacha: Repairing a Pediatric “Swiss Cheese” Heart
https://reachmd.com/programs/medical-industry-feature/the-case-of-a-swiss-cheese-septum-repairing-a-pediatric-heart/24449/Ventricular septal defects (VSD) can be a challenging defect of the heart to treat. Dive in to find out what this doctor did to save a young boy’s life.Harnessing DED Data: Comparison Studies
https://reachmd.com/clinical-practice/optometry/harnessing-ded-data-comparison-studies/28667/Join Laura M. Periman, MD; Mile Brujic, OD, FAAO; and Jessica Steen, OD, FAAO, as they discuss dry eye disease. In this podcast, Dr. Steen discusses recent comparison studies. This content was captured during a live-virtual symposium. Polling took place during the symposium. This activity is suppoHow to Create Synergy Between LGBTQ+ Youth, Parents, and Clinicians
https://reachmd.com/programs/clinicians-roundtable/how-to-create-synergy-between-lgbtq-youth-parents-and-clinicians/16140/How can we foster synergistic relationships between parents and LGBTQ+ youth? Find out with this recap of a session featured at ANAC 2023.